[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Bsjjsjsjjs完成签到,获得积分10
1秒前
LY_Qin完成签到,获得积分0
2秒前
隐形曼青应助武雨寒采纳,获得10
2秒前
AKIN发布了新的文献求助10
3秒前
3秒前
WSY发布了新的文献求助10
3秒前
李优秀发布了新的文献求助10
4秒前
活泼山雁发布了新的文献求助10
4秒前
4秒前
Bsjjsjsjjs发布了新的文献求助10
5秒前
小二郎应助鹂鹂复霖霖采纳,获得10
5秒前
wanci应助善良的觅云采纳,获得10
5秒前
5秒前
6秒前
Nancy完成签到 ,获得积分10
6秒前
6秒前
6秒前
7秒前
大模型应助yun采纳,获得10
8秒前
ArkZ完成签到 ,获得积分0
8秒前
8秒前
sll发布了新的文献求助10
10秒前
EDTA发布了新的文献求助10
10秒前
考拉完成签到,获得积分10
10秒前
Owen应助傅剑寒采纳,获得10
10秒前
www发布了新的文献求助10
10秒前
Zutter发布了新的文献求助10
11秒前
11秒前
miniwuye完成签到,获得积分10
11秒前
12秒前
丰台第一深情完成签到,获得积分10
12秒前
善良的觅云完成签到,获得积分10
12秒前
一般啊发布了新的文献求助10
12秒前
13秒前
luohao发布了新的文献求助10
13秒前
xia完成签到,获得积分10
13秒前
星辰大海应助ritanon采纳,获得10
14秒前
想瘦的海豹完成签到,获得积分10
14秒前
隐形曼青应助文静绮梅采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
The SAGE Dictionary of Qualitative Inquiry 610
Signals, Systems, and Signal Processing 610
An Introduction to Medicinal Chemistry 第六版习题答案 600
On the Dragon Seas, a sailor's adventures in the far east 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6345795
求助须知:如何正确求助?哪些是违规求助? 8160459
关于积分的说明 17162158
捐赠科研通 5401910
什么是DOI,文献DOI怎么找? 2860950
邀请新用户注册赠送积分活动 1838784
关于科研通互助平台的介绍 1688145